Genix Pharmaceuticals Corporation
GENPF
$0.01
-$0.02-53.00%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -239.40K | -60.10K | -59.30K | -86.00K | -54.20K |
| Total Depreciation and Amortization | -- | -600.00 | -400.00 | -200.00 | 0.00 |
| Total Amortization of Deferred Charges | 800.00 | 1.40K | 1.20K | 1.00K | 800.00 |
| Total Other Non-Cash Items | 126.80K | -80.40K | -87.20K | -83.90K | -106.10K |
| Change in Net Operating Assets | 23.50K | 44.30K | 28.10K | 18.40K | 21.80K |
| Cash from Operations | -88.20K | -95.40K | -117.50K | -150.60K | -137.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 87.30K | 127.80K | 158.40K | 201.70K | 187.10K |
| Total Debt Repaid | -30.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 100.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.10K | -- | -- | -- | -- |
| Cash from Financing | 111.50K | 91.60K | 113.90K | 146.40K | 137.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.30K | -3.90K | -3.60K | -4.20K | -100.00 |